Month: February 2025

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (the “Company”) is pleased to announce it has closed its previously announced offering of 5.25% convertible senior notes due 2030 (the “Notes”) in an aggregate principal amount of $110 million (the “Offering”), which includes the upsized offering of $95 million and the exercise in full of the $15 million option granted to the initial purchasers of the Notes. All amounts are in United States Dollars. The initial conversion rate for the Notes is 88.9284 shares of the Company’s common stock per $1,000 principal amount of Notes, equivalent to an initial conversion price of approximately $11.25 per share, which represents a premium of approximately 30% to the closing sale price of the Company’s common stock on February 6th, 2025; the capped call(1) has...

GOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionGOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionSaqib Islam, SpringWorks Therapeutics CEOSaqib Islam, SpringWorks Therapeutics CEOSpringWorks Therapeutics, IncSpringWorks Therapeutics, Inc.GOMEKLI™ (mirdametinib) logoGOMEKLI™ (mirdametinib) logo– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data from Phase 2b ReNeu trial, which showed GOMEKLI treatment resulted in robust ORR, deep and durable reductions in tumor volume, and a manageable safety profile – – SpringWorks granted rare pediatric disease priority review voucher by the FDA – Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/8eb8effc-49a5-4b24-911f-d3e6dfa9c8a9https://www.globenewswire.com/NewsRoom/AttachmentNg/f1041678-3f79-43b7-a101-2390fb8cb86bhttps://www.globenewswire.com/NewsRoom/AttachmentNg/7d8cb318-e5f8-4944-8736-24cb19a5dec9https://www.globenewswire.com/NewsRoom/AttachmentNg/072d748b-3237-48ad-8d83-1c6c23dda65f STAMFORD,...

HAMILTON, Bermuda, Feb. 11, 2025 (GLOBE NEWSWIRE) — Teekay Corporation Ltd. (Teekay) (NYSE:TK) and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) (collectively, the Teekay Group) plan to release their financial results for the fourth quarter and annual 2024 after market close on Wednesday, February 19, 2025. The Teekay Group plans to host a conference call on Thursday, February 20, 2025 at 11:00 a.m. (ET) to discuss its results for the fourth quarter and annual 2024. All shareholders and interested parties are invited to listen to the live conference call by choosing from the following options:By dialing 1(800) 289-0438, or 1(647) 484-0478 if outside of North America, and quoting conference ID code 5649868. By accessing the webcast, which will be available on the Teekay Group’s website at www.teekay.com (the archive will remain...

ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2024 fourth quarter and full year financial results on Tuesday, February 25, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors page of the company’s website at www.axogeninc.com and clicking on the webcast link. Following...

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) — Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand, today announced the successful closing of its Rule 144A/Reg S private offering (the “Offering”) of $637.5 million in aggregate principal amount of 10.000% senior secured notes due 2030 (the “Notes”) at an issue price of 98.087% of the principal amount thereof in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The size of the Offering was increased from the previously announced $625.0 million aggregate principal amount. The Notes will be guaranteed, jointly and severally on a secured, unsubordinated basis by Outbrain and each existing and future wholly owned subsidiary of Outbrain that becomes a borrower, issuer or guarantor under Outbrain’s super senior...

Scaling to meet explosive demand for POET’s AI infrastructure hardware TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company“) (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for Artificial Intelligence networks, today issued its “2025 Outlook” letter to shareholders from its Chairman and Chief Executive Officer, Dr. Suresh Venkatesan, providing a review of the market, the Company’s customers, the progress toward meeting the demand for AI infrastructure and an early look at what the Company is planning for 2025, including its participation in the Optical Fiber Communications Conference (OFC) in San Francisco (March 31-April 3, 2025). Turning Vision into RealityPOET’s strategic vision of becoming...